Wolverine Blend (BPC-157 + TB-500) 5mg — Vial Spec, Reconstitution Math & COA

A 5mg Wolverine Blend vial combines BPC-157 and TB-500 (Thymosin Beta-4 derivative) into a single lyophilized matrix designed for high-precision in vitro and preclinical research. This targeted vial size is ideal for small-scale pilot assays, short-duration animal models, or preliminary binding studies that require high purity without excessive reagent volume. Here we outline the complete technical specification, reconstitution calculations, storage parameters, and batch-matched analytical documentation.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

A 5mg Wolverine Blend vial combines BPC-157 and TB-500 (Thymosin Beta-4 derivative) into a single lyophilized matrix designed for high-precision in vitro and preclinical research. This targeted vial size is ideal for small-scale pilot assays, short-duration animal models, or preliminary binding studies that require high purity without excessive reagent volume. Here we outline the complete technical specification, reconstitution calculations, storage parameters, and batch-matched analytical documentation.

Reviewed by PX1 Research scientific team

Key takeaways

  • The term 'Wolverine Blend 5mg' typically refers to a co-lyophilized research preparation containing synthetic [BPC-157](/research-peptides/bpc-157) and [TB-500](/research-peptides/tb-500).
  • The combination of [BPC-157](/research-peptides/bpc-157) (Body Protection Compound 157) and [TB-500](/research-peptides/tb-500) (synthetic sequence matching the active region of Thymosin Beta-4) is widely investigated in cellular repair, extracellular matrix (ECM) reorganization, and tissue regeneration models.
  • Accurate reconstitution is vital for maintaining target concentrations in benchtop experiments.
  • To safeguard peptide integrity and avoid repeated freeze-thaw degradation, working stock solutions should be aliquoted immediately following complete dissolution.

Product Specification and Catalog Availability

The term 'Wolverine Blend 5mg' typically refers to a co-lyophilized research preparation containing synthetic BPC-157 and TB-500. Depending on laboratory research requirements, this formulation may be scaled as a total mass of 5mg (2.5mg BPC-157 + 2.5mg TB-500) or provided in standard 10mg combined formats containing 5mg of each peptide constituent. Researchers evaluating low-volume assay protocols often select 5mg total preparations to prevent repeated freeze-thaw cycles and minimize peptide degradation during multi-day experimental runs.

PX1 Research maintains rigorous manufacturing controls for all blended cytoprotective peptides. While specialized pilot batches are made available for high-throughput screening projects, our standardized, off-the-shelf inventory features the high-concentration BPC-157 5mg + TB-500 5mg Wolverine Blend. For investigators seeking single-entity control vials or alternative mass specifications, our comprehensive all peptides catalog provides individual 5mg vials of each isolate for comparative baseline studies.

Preclinical Mechanisms of BPC-157 and TB-500 in Synergistic Research

The combination of BPC-157 (Body Protection Compound 157) and TB-500 (synthetic sequence matching the active region of Thymosin Beta-4) is widely investigated in cellular repair, extracellular matrix (ECM) reorganization, and tissue regeneration models. BPC-157 is a pentadecapeptide derived from human gastric juice protein fragments. In vitro and rodent models suggest BPC-157 upregulates vascular endothelial growth factor receptor 2 (VEGFR2) expression, promotes early endothelial tube formation, and modulates the focal adhesion kinase (FAK) / paxillin signaling pathway to enhance cell migration.

In contrast, TB-500 functions primarily through G-actin sequestration and actin filament polymerization. Preclinical research demonstrates that TB-500 downregulates pro-inflammatory cytokines while facilitating cell motility, dermal remodeling, and collagen deposition. When co-administered in culture or animal models, preclinical studies suggest the two compounds exert complementary cytoprotective effects: BPC-157 stimulates microvascular sprouting and nitric oxide pathways, whereas TB-500 accelerates cell migration into the newly vascularized matrix. Detailed mechanisms can be explored further in our research library.

Reconstitution Math and Concentration Calculations for 5mg Vials

Accurate reconstitution is vital for maintaining target concentrations in benchtop experiments. When working with a total 5mg co-lyophilized peptide mass, addition of bacteriostatic water or sterile normal saline yields specific working concentrations based on total liquid volume added. Researchers can utilize our online reconstitution calculator to verify laboratory math prior to assay preparation.

For a 5mg aggregate vial (or a vial containing 2.5mg BPC-157 and 2.5mg TB-500), standard diluent additions yield the following concentration profiles:

1.0 mL Diluent Addition: 5.0 mg / 1.0 mL = 5.0 mg/mL total peptide concentration (or 2.5 mg/mL of each individual peptide constituent). A 10 µL micropipette aliquot delivers 50 µg total peptide (25 µg BPC-157 / 25 µg TB-500).

2.0 mL Diluent Addition: 5.0 mg / 2.0 mL = 2.5 mg/mL total peptide concentration (1.25 mg/mL per constituent). A 10 µL micropipette aliquot delivers 25 µg total peptide (12.5 µg per constituent).

3.0 mL Diluent Addition: 5.0 mg / 3.0 mL = 1.67 mg/mL total peptide concentration (0.833 mg/mL per constituent). A 10 µL micropipette aliquot delivers 16.7 µg total peptide (8.33 µg per constituent).

If reconstituting the PX1 flagship 10mg Wolverine Blend (5mg BPC-157 + 5mg TB-500), doubling these concentration outputs yields 10 mg/mL, 5 mg/mL, or 3.33 mg/mL total peptide mass respectively.

Aliquot Planning and Laboratory Handling Protocols

To safeguard peptide integrity and avoid repeated freeze-thaw degradation, working stock solutions should be aliquoted immediately following complete dissolution. Synthetic peptides dissolved in aqueous media are subject to hydrolytic cleavage and peptide aggregation if stored at ambient temperatures or subjected to multiple temperature cycles.

Investigators should draw the reconstituted solution using sterile techniques inside a laminar flow hood. Divide the solution into single-use polypropylene low-binding microcentrifuge tubes according to the planned daily assay volume. Aliquots intended for use within 48 to 72 hours may be refrigerated at 2°C to 8°C. Long-term storage of reconstituted aliquots requires rapid freezing at -20°C or -80°C. Avoid frost-free freezers, as their automatic temperature fluctuations induce crystal formation that denatures secondary peptide structure.

Analytical Quality Assurance: HPLC, MS, and COA Issuance

Co-lyophilized peptide blends demand rigorous analytical validation to guarantee that both individual constituents are present in exact stoichiometric ratios without cross-reactivity or breakdown during synthesis and freeze-drying. PX1 Research validates every lot through independent ISO 17025 accredited laboratories.

High-Performance Liquid Chromatography (HPLC) is conducted to verify chromatographic purity (typically ≥98.0%), resolving distinct elution peaks for both BPC-157 and TB-500 without interfering synthesis side-products. Mass Spectrometry (MS) confirms the exact molecular weights of both sequence structures. Furthermore, every batch undergoes chromogenic LAL testing to ensure bacterial endotoxin levels remain strictly below <0.01 EU/mg, preventing confounding inflammatory responses in sensitive cell lines or rodent models. Researchers can review batch-specific documentation directly via our COA portal.

Comparative Analysis: Wolverine Blend vs. Cytoprotective and Anabolic Class Alternatives

In tissue repair and metabolic research, investigators frequently compare the Wolverine Blend against standalone peptides or secretagogue combinations. While the BPC-157 and TB-500 pairing targets localized cellular migration, focal adhesion, and actin dynamics, other research compounds target distinct physiological pathways:

For instance, researchers studying systemic extracellular matrix repair often evaluate standalone BPC-157 or isolated TB-500 to isolate single-variable signaling cascades. In contrast, laboratories examining growth hormone receptor pathways or pituitary-driven regenerative responses may utilize growth hormone secretagogues such as Ipamorelin or CJC-1295. While growth hormone secretagogues elevate IGF-1 expression to drive broad metabolic downstream signaling, the Wolverine Blend operates via direct localized cellular mechanisms independent of the hypothalamic-pituitary axis.

Storage Parameters and Degradation Pathways

Lyophilized Wolverine Blend vials are stable at controlled room temperature (15°C to 25°C) for short-term transit, but must be stored at -20°C upon receipt for extended shelf-life. Protect lyophilized vials from direct light exposure by storing them in original packaging or amber storage boxes.

Primary chemical degradation pathways for dissolved BPC-157 and TB-500 include deamidation at asparagine and glutamine residues, oxidation of methionine residues, and peptide bond hydrolysis under non-neutral pH conditions. Maintaining reconstituted solutions in buffered, sterile diluents (pH 6.0–7.4) at low temperatures minimizes these degradation routes, ensuring consistent receptor binding and cellular responses across extended experimental timeframes.

Selecting the Right Specimen Size: 5mg vs. 10mg Vials

Choosing between a 5mg total blend vial and a 10mg (5mg + 5mg) blend vial depends primarily on experimental throughput, dilution volume, and assay duration. Smaller 5mg preparations are optimal for preliminary in vitro viability screenings, enzymatic binding assays, or small animal pilot studies where only microgram quantities are required per experiment.

For high-volume multi-week animal studies, multi-well cell culture panels, or institutional research labs, larger 10mg combination vials or purchasing through our wholesale program offers greater operational efficiency and reduced cost per milligram. Evaluating assay schedules prior to ordering prevents unnecessary peptide decay in reconstituted storage.

Frequently Asked Questions

What exact composition is in a 5mg Wolverine Blend vial?

Depending on specific lot formulations, a 5mg Wolverine Blend vial contains either a total co-lyophilized mass of 5mg (split as 2.5mg BPC-157 and 2.5mg TB-500) or represents a specific pilot size. PX1 Research standardizes catalog inventory on the [10mg Wolverine Blend](/product/bpc-157-5mg-tb-500-5mg-wolverine-blend) containing 5mg of each peptide isolate.

How is the concentration calculated when adding 2mL of water to a 5mg total vial?

Adding 2.0 mL of sterile bacteriostatic water to a 5mg total peptide vial yields a final working concentration of 2.5 mg/mL of total peptide (or 1.25 mg/mL for each component if divided 1:1). Use our [reconstitution calculator](/reconstitution-calculator) for precise conversions.

Where can I download the Certificate of Analysis (COA) for my lot?

Batch-specific COAs detailing HPLC purity, Mass Spectrometry verification, and endotoxin levels are available on our dedicated [COA lookup page](/coa).

What is the endotoxin limit for PX1 Wolverine Blend research vials?

All PX1 Research peptide lots are tested via chromogenic LAL assays to ensure bacterial endotoxin levels remain strictly below <0.01 EU/mg, ensuring suitability for sensitive cell culture and animal models.

How long does reconstituted Wolverine Blend remain stable?

Reconstituted peptide solutions maintained in sterile bacteriostatic water are stable at 2°C to 8°C for up to 28 days. Single-use aliquots frozen at -20°C or -80°C remain stable for up to 3–6 months.

Is the Wolverine Blend approved for human clinical use or injection?

No. All products sold by PX1 Research, including the Wolverine Blend, are strictly intended for laboratory in vitro and preclinical research use only. They are not for human or veterinary use, therapy, or clinical application.

How does Wolverine Blend compare to single BPC-157 research vials?

Single [BPC-157](/research-peptides/bpc-157) vials permit isolation of specific VEGFR2 and NO signaling pathways. Wolverine Blend combines BPC-157 with [TB-500](/research-peptides/tb-500) to simultaneously observe G-actin sequestration and cell migration alongside focal adhesion dynamics.

What diluents should be used for reconstituting Wolverine Blend?

Bacteriostatic water (0.9% benzyl alcohol) is recommended for multi-dose laboratory handling over 28 days. Sterile 0.9% Sodium Chloride or phosphate-buffered saline (PBS) may be used for immediate in vitro cell culture assays where benzyl alcohol is contraindicated.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.